Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
GalaxoSmithKline received FDA approval for an expanded use of its severe asthma drug Nucala and granted the drug Orphan status.
Eli Lilly is forecasting revenue of $23 billion to $23.5 billion and adjusted earnings of $4.60 to $4.70 per share in 2018, according to CNBC.
A group of institutional investors, with more than $400 billion of assets, is urging big pharmaceutical manufacturers to begin reporting links between drug pricing strategies and executive compensation, according to Bloomberg.
Here are the four latest drugs or medical devices approved by the FDA since Dec. 1.
The FDA plans to publish a draft guidance during the first quarter of 2018 outlining an alternative pathway for device manufacturers seeking 510(k) clearance, FDA Commissioner Scott Gottlieb, MD, wrote in a agency blog post Dec. 11.
The FDA approved Boston Scientific Corp.'s Vercise Deep Brain Stimulation System to treat the symptoms of Parkinson's disease.
The FDA approved Sanofi SA's Admelog Monday, which is a biosimilar of Eli Lilly's fast-acting insulin.
Nearly 96 percent of U.S. pharmaceutical sales were brought to the market through pharmaceutical distributors in 2016, according to a new report published by the HDA Research Foundation, a healthcare supply chain research firm.
Becker's Hospital Review has reported the following 10 drug company layoffs in the past two months. They are listed below, beginning with the most recent.
Pharmaceutical giant Sanofi Pasture urged the Philippine government Monday to lift the suspension of its dengue vaccine, arguing it is still safe, according to the U.K. Daily Mail.